Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 15.04
-4.75 %
$ 1.93 B
Market Cap
-24.66
P/E
Price Target
Average
28.23%
Revenue Forecast
Estimate
13.43%
EBIT
Estimate
8.33%
Net Income
Estimate
39.72%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
NeoGenomics, Inc.
Wall Street analysts predict an average 1-year price target for NEO of $19.3 , with forecasts ranging from a low of $18 to a high of $21 .
NEO Lowest Price Target
Wall Street Target
18 USD
19.68%
NEO Average Price Target
Wall Street Target
19.3 USD
28.23%
NEO Highest Price Target
Wall Street Target
21 USD
39.63%
REVENUE FORECAST
Revenue Forecast Chart NEO
EBIT FORECAST
EBIT Forecast Chart NEO
NET INCOME FORECAST
Net Income Chart NEO